The efficiency of dyslipidemia control in real clinical practice and the possibilities of its correction in patients with coronary heart disease and diabetes mellitus in the long -term use of simvastatin

The efficiency of dyslipidemia control in real clinical practice and the possibilities of its correction in patients with coronary heart disease and diabetes mellitus in the long -term use of simvastatin

Show other versions (1)

<p><strong>Objective:</strong> To show the efficiency of dyslipidemia control in patients with coronary heart disease (CHD) and diabetes mellitus (DM) in real outpatient clinical practice and the possibilities of its correction in the long-term use of simvastatin (simvastatin forte...

Full description

Bibliographic Details
Main Authors:	F. Yu. Valikulova, I. V. Fomin
Format:	Article
Language:	Russian
Published:	ABV-press 2014-07-01
Series:	Klinicist
Subjects:	coronary heart disease diabetes mellitus hyperlipidemia simvastatin forte
Online Access:	http://klinitsist.abvpress.ru/index.php/Klin/article/view/28

Similar Items

The efficiency of dyslipidemia control in real clinical practice and the possibilities of its correction in patients with coronary heart disease and diabetes mellitus in the long -term use of simvastatin
by: F. Yu. Valikulova, et al.
Published: (2014-07-01)

Antioxidant effects of simvastatin in patients with coronary heart disease and dyslipidemia
by: N. E. Artamoshina, et al.
Published: (2012-12-01)

EXPLORING LIPID LOWERING ACTIVITY OF CASSIA FISTULA AND SIMVASTATIN, IN HYPERLIPIDEMIC MICE
by: Usman Nawaz, et al.
Published: (2019-06-01)

Study of the Functional State of the Proximal Renal Tubules in Patients with Asymptomatic Chronic Heart Failure in Dyslipidemia and its Correction with Simvastatin Treatment
by: V. Yu. Kopylov
Published: (2020-12-01)

Clinical effects of statins: focusing on simvastatin
by: D. M. Aronov, et al.
Published: (2009-04-01)

The Effect of Simvastatin on Gut Microbiota and Lipid Metabolism in Hyperlipidemic Rats Induced by a High-Fat Diet
by: Qing Zhang, et al.
Published: (2020-04-01)

Simvastatin and Captopril Combined Transdermal Delivery System for Controlling Blood Pressure and Fat: Design, Characterization, and In Vivo Pharmacokinetic Evaluation
by: Ya-Jing Ni, et al.
Published: (2024-10-01)

EFFECT OF SIMVASTATIN ON MARKERS OF CARDIOVASCULAR RISK
by: N. V. Perova, et al.
Published: (2016-01-01)

The effect of use simvastatin at treatment of ischemic heart disease patients of senile age
by: A. L. Pirogov, et al.
Published: (2007-10-01)

Rosuvastatin safety and efficacy in coronary heart disease patients
by: I. V. Sergienko, et al.
Published: (2006-10-01)

Revolutionizing Hyperlipidemia Treatment: Nanoencapsulated CoQ10 and Selenium Combat Simvastatin-Induced Myopathy and Insulin Resistance in Rats
by: Hagar B. Abo-Zalam, et al.
Published: (2024-07-01)

Simvastatin ameliorates oxidative stress levels in HepG2 cells and hyperlipidemic rats
by: Kanika Verma, et al.
Published: (2022-01-01)

EFFICIENCY AND SAFETY ASSESSMENT OF GENERIC ATORVASTATINE IN PATIENTS WITH HYPERLIPIDEMIA
by: J. E. Semyonova, et al.
Published: (2015-12-01)

Simvastatin therapy in elderly patients with chronic heart failure: potential cardiodepressive effects
by: A. L. Pirogov, et al.
Published: (2008-10-01)

EFFECT OF SIMVASTATIN THERAPY ON INDICATORS OF TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE
by: T. V. Pinchuk, et al.
Published: (2015-09-01)

ESCADRA: a randomised study. Part I: lipid-lowering effectiveness, safety and tolerability of ezetimibe, initial doses of original statins, and the combination of ezetimibe with initial doses of statins in patients with coronary heart disease and hyperlipidemia
by: M. Yu. Zubareva, et al.
Published: (2010-12-01)

Interventional cardiology and diabetes mellitus: age of effective coronary heart disease treatment
by: Victor Yur'evich Kalashnikov, et al.
Published: (2011-03-01)

Bacteriostatic effect of simvastatin on selected oral streptococci in vitro
by: Eugene J Whitaker, et al.
Published: (2017-01-01)

ANTIISCHEMIC AND ANTIARRHYTHMIC EFFECTS OF SIMVASTATIN IN PATIENTS WITH DIASTOLIC HEART FAILURE
by: T. V. Pinchuk, et al.
Published: (2013-12-01)

Effects of Silymarin on the In Vivo Pharmacokinetics of Simvastatin and Its Active Metabolite in Rats
by: Ying Li, et al.
Published: (2019-04-01)

Simvastatin-induced Toxic Epidermal Necrolysis
by: Emmanouil Petrou, et al.
Published: (2014-01-01)

Metabolite Signature of Simvastatin Treatment Involves Multiple Metabolic Pathways
by: Lilian Fernandes Silva, et al.
Published: (2022-08-01)

Safety of Simvastatin and Goal Attainment for Low-Density Lipoprotein Cholesterol in Sultan Qaboos University Hospital
by: Khalid Al-Siyabi, et al.
Published: (2010-10-01)

DYSLIPIDEMIA AND SEVERITY OF ATHEROSCLEROTIC CORONARY ARTERY DISEASE IN PATIENTS WITH ACUTE CORONARY SYNDROME AND SUBCLINICAL HYPOTHYROIDISM
by: E.B. PETROVA, et al.
Published: (2022-09-01)

Assessment of risk factors for coronary artery disease in patients with ischemic heart disease in the Southern region of India
by: Lekshmy S Nair, et al.
Published: (2024-05-01)

The Suppression of Medulloblastoma Cell Migration Using Clinically Significant Doses of Simvastatin through Mevalonate Pathway Targeting
by: Charley Comer, et al.
Published: (2024-03-01)

In-vitro Examination of The Potential Antibacterial Activity of Simvastatin
by: Hani Almukhtar, et al.
Published: (2020-12-01)

Dyslipidemia correction with atorvastatin in patients with coronary heart disease and arterial hypertension
by: N. B. Amirov, et al.
Published: (1970-01-01)

Efficacy of Adding Topical Simvastatin to Topical Calcipotriol On Improvement of Cutaneous Plaque Psoriasis
by: Fariba Iraji, et al.
Published: (2015-03-01)

In vitro synergism of simvastatin and fluconazole against Candida species
by: Everardo Albuquerque Menezes, et al.
Published: (2012-08-01)

The effect of Simvastatin in attenuation of Myocardial Ischemia/ Reperfusion injury
by: Najah Raiesh Hadi, et al.
Published: (2013-12-01)

Investigation of risk factors to coronary heart disease in two countryside villages
by: Gisleine Elisa Cavalcante da Silva, et al.
Published: (2004-07-01)

Simvastatin attenuates the c-Raf/Erk and calcineurin-NFATc2 pathways via inhibition of Hsp90 activity during the development of heart failure
by: Tetsuro Marunouchi, et al.
Published: (2023-01-01)

Simvastatin, Its Antimicrobial Activity and Its Prevention of Alzheimer’s Disease
by: Sudip Dhakal, et al.
Published: (2024-06-01)

Effects of Simvastatin on Pharmacokinetics and Anticoagulant Effects of Dabigatran in Healthy Subjects
by: Hyewon Chung, et al.
Published: (2023-02-01)

Sub-gingival delivery of simvastatin and rosuvastatin for treatment of chronic periodontitis with diabetes mellitus: A randomized controlled clinical-radiographic pilot study
by: Pallavi Sharma, et al.
Published: (2023-03-01)

Increased intravascular platelet activity in metabolic syndrome patients, and its correction by simvastatin treatment
by: N. I. Gromnatsky, et al.
Published: (2004-12-01)

Simvastatin Attenuated Tumor Growth in Different Pancreatic Tumor Animal Models
by: Chao-Yi Chen, et al.
Published: (2022-11-01)

Lipid metabolism correction in elderly patients with Type 2 diabetes mellitus
by: L. G. Gonokhova
Published: (2006-08-01)

Anti-Hyperlipidemic Effect of Zinc complex of Betulinic acid in High Fat Diet- Induced Hyperlipidemia
by: Mehwish Tayyab, et al.
Published: (2023-04-01)